Tenon Medical (TNON)

The sacroiliac joint sits between the spine and pelvis and can become painful because of degeneration, trauma, prior lumbar fusion, or other mechanical issues. Tenon Medical targets physicians who perform procedures for patients who have not achieved sufficient relief from conservative care. Its technology is intended to offer a less invasive alternative to more extensive surgical approaches while still providing strong fixation across the joint.

The company’s commercial strategy is built around three main opportunities: primary sacroiliac joint fusion procedures, revision of failed or inadequate prior implants, and use of sacroiliac fusion as an adjunct to larger spine fusion constructs. Revenue is generated mainly through sales of The Catamaran System, and the company remains dependent on adoption by a relatively concentrated group of surgeons and clinicians.

Tenon Medical operates in the broader spine and orthopedic device market, where clinical outcomes, surgeon training, reimbursement, and hospital purchasing decisions all play important roles. Its investment profile is closely tied to procedure growth, evidence supporting its implant system, expansion of its surgeon user base, and the company’s ability to compete with larger medical device manufacturers that also serve the sacroiliac joint and spine surgery markets.